Bank Sinarmas Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Bank Sinarmas Tbk trades at Rp695 (market cap 13.56T, 16.1K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp146 (market cap 584.6B, 817.3K 24h volume). The key difference: Bank Sinarmas Tbk is far larger — about 23.2× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (817.3K versus 16.1K). Which is the better fit depends on your goals.
| BSIM | LABS | |
|---|---|---|
Market Cap | 13.56T | 584.6B |
Volume | 16.1K | 817.3K |
Lot | 161 | 8.17K |
Turnover | 11.29M | 120.01M |
Average Price | 700.99 | 146.84 |
Value | 11.29M | 120.01M |
Indicative Equilibrium Price | 700 | 146 |
Indicative Equilibrium Volume | 1 | 59 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bank Sinarmas (the company) was established under its original name of PT Bank Shinta Indonesia base on notarial deed No.52 of Mr Buniarti Tjandra, S.H, dated on 18 Aug, 1989. The Company’s articles of association has been amended several times, most recently by notarial deed No.31 of Sutjipto, S.H., dated Apr 6 2010, concerning among others, change in par value, the name of the company, and public offering.
Read more on BSIM →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →